SEREVENT
- Product NDC
- 0173-0520
- 11-digit product format
- 001730520
- Labeler code
- 0173
- Product ID
- 0173-0520_3d3e1ca0-f3aa-4b93-aef7-116e75102620
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- salmeterol xinafoate
- Dosage form
- POWDER, METERED
- Route
- ORAL; RESPIRATORY (INHALATION)
- Labeler
- GlaxoSmithKline LLC
- Application
- NDA020692
- Marketing category
- NDA
- Marketing start
- 1997-12-01
- Marketing end
- 2021-12-31
- Substance
- SALMETEROL XINAFOATE
- Active strength
- 50 ug/1
- Pharmacologic classes
- Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0173-0520-00 | 00173052000 | 1 INHALER in 1 CARTON (0173-0520-00) > 28 POWDER, METERED in 1 INHALER | 1 inhaler | 1997-12-01 | 2021-12-31 | No | No | Current |